2014, Number 3
<< Back Next >>
Rev Odont Mex 2014; 18 (3)
Periodontal disease in adolescent Down’ syndrome patients. Clinical case presentation
Benítez TM, López MP, Yamamoto NA
Language: Spanish
References: 32
Page: 191-198
PDF size: 462.74 Kb.
ABSTRACT
Down’s syndrome or trisomy 21 is man’s most frequent genetic disorder. It affects one out of 600-700 live births. It is characterized by the presence of an additional chromosome at the 21 pair which elicits generalized decrease of growth as well as intellectual disability. In scientific literature there are many reports of cranio-facial and oral manifestations of this disorder. Chief oral condition reported in this group of patients is periodontal disease.
Objective: Establishment of preventive oral care for the development of periodontal disease in adolescent patients afflicted with Down’s syndrome.
Case presentation: 15 year old Mexican-Indian male patient with trisomy 21. The patient was bilingual, afflicted with congenital heart disease, pulmonary hypertension and nephrotic syndrome. The patient equally presented ectopic dental eruption as well as congenital dental absences, Angle’s class III occlusion, anterior and posterior unilateral crossbite, oral respiration, labial eversion, fissured tongue and lips, clinodactyly and localized gingivitis. Behavior management was achieved with the «show-tell-do» technique alongside with voice control. Initial treatment consisted on sweeping brushing technique with parental assistance, use of dental floss (Dento Bacterial Plaque Control [DBPC]) (100%) as well as topical application of fluoride varnish. It was recommended to the parents they should use home applications of bioadhesive gel (Perioxidin
®). After these measures, oral rehabilitation was undertaken.
Conclusions: The most relevant aspect of the treatment was the decrease (40%) in bacterial plaque reported in later control visits.
REFERENCES
Fundación Iberoamericana Down 21 [Internet].www.down21.org/
Cichon P, Crawford L, Grimm WD. Early-onset periodontitis associated with Down’s syndrome-A clinical interventional study. Ann Periodontol. 1998; 3 (1): 370-80.
López P, López R, Parés G, Borges SA, Valdespino L. Reseña histórica del síndrome de Down. Rev ADM. 2000; LVII (5): 193-9.
López R, López P, Borges SA, Parés G. Caries dental en niños con trisomía 21. Bol Med Hosp Infant Mex. 2000; 57 (8): 437-42.
Amano A, Kishima T, Kimura S, Takiguchi M, Ooshima T, Hamada S, Morisaki I. Periodontopathic bacteria in children with Down syndrome. J Periodontol. 2000; 71 (2): 249-55.
Amano A, Kishima T, Akiyama S, Nakagawa I, Hamada S, Morisaki I. Relationship of periodontopathic bacteria with early-onset periodontitis in Down’s syndrome. J Periodontol. 2001; 72 (3): 368-73.
López R, López P, Borges SA, Parés G, Valdespino L. Gingivitis en una comunidad infantil mexicana con trisomía 21. DEPeI. 2000; 3-4 (11-14): 5-13.
Bagic I, Verzak Z, Cukovic-Cavka S, Brkic H, Susic M. Periodontal conditions in individuals with Down’s syndrome. Coll Antropol. 2003; 27 supl 2 (1): 75-82.
López J, Rosello X. Síndrome de Down y enfermedad periodontal. Estudio clínico. Rev Eur Odont Estomatol. 1995; 7 (2): 85-90.
Sohoel PDC, Johannessen AC, Kristoffersen T, Nilsen R. Expression of HLA class II antigens in marginal periodontitis of patients with Down’s syndrome. Eur J Oral Sci. 1995; 103 (4): 207-13.
Reuland-Bosma W, van der Reijden WA, van Winkelhoff AJ. Absence of a specific subgingival microflora in adults with Down’s syndrome. J Clin Periodontol. 2001; 28 (11): 1004-9.
Morinushi T, Lopatin DE, Van Poperin N. The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down’s syndrome. J Periodontol. 1997; 68 (7): 626-31.
Barr-Agholme M, Dahllöf G, Modeér T, Engström P, Norhagen G. Periodontal conditions and salivary immunoglobulins in individuals with Down syndrome. J Periodontol. 1998; 69 (10): 1119-23.
López P, Borges SA, Jiménez G, Maupomé G. Oral hygiene, gingivitis and periodontitis in persons with Down syndrome. Spec Care Dentist. 2002; 22 (6): 214-20.
Halinen S, Sorsa T, Ding Y, Ingman T, Salo T, Konttinen YT, Saari H. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down’s syndrome. J Periodontol. 1996; 67 (8): 748-54.
Cutress TW. Periodontal disease and oral hygiene in trisomy 21. Archs Oral Biol. 1971; 16 (8): 1345-55.
Onyeaso CO, Fasola AO, Arowojolu MO. Dentofacial findings in Down’s syndrome: report of case. Afr J Med Sci. 2002; 31 (1): 71-4.
Zaldivar-Chiapa RM, Arce-Mendoza AY, De la Rosa-Ramírez M, Caffesse RG, Solis-Soto JM. Evaluation of surgical and non-surgical periodontal therapies, and immunological status, of young Down’s syndrome patients. J Periodontol. 2005; 76 (7): 1061-5.
Barr-Agholme M, Krekmanova L, Yucel-Lindberg T, Shinoda K, Modeér T. Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand. 1997; 55 (2): 101-5.
Shaw L, Saxby MS. Periodontal destruction in Down’s syndrome and in juvenile periodontitis. How close a similarity? J Periodontol. 1986; 57 (11): 709-15.
Sakellari D, Arapostathis KN, Konstantinidis A. Periodontal conditions and subgingival microflora in Down syndrome patients. A case-control study. J Clin Periodontol. 2005; 32 (6): 684-90.
Bradley C, McAlister T. The oral health of children with Down syndrome in Ireland. Spec Care Dentist. 2004; 24 (2): 55-60.
Hernández JR, Tello T, Hernández FJ, Rosette R. Enfermedad periodontal: prevalencia y algunos factores asociados en escolares de una región mexicana. Rev ADM. 2000; LVII (6): 222-30.
The American Academy of Periodontology [Internet]. www.perio.org.
Barrios G. Odontología: su fundamento biológico. Tomo III. Iatros Ediciones Ltda. 1991: 674-81.
Sasaki Y, Sumi Y, Miyazaki Y, Hamachi T, Nakata M. Periodontal management o fan adolescent with Down’s syndrome. A case report. Int J Paediat Dent. 2004; 14 (2): 127-35.
Harris N, García-Godoy F. Odontología preventiva primaria. Ed. El Manual Moderno. 5a ed. 2001: 401-21.
Usher P. Oral hygiene in mentally handicapped children. A pilot study of the use of chlorhexidine gel. Brit dent J. 1975; 138 (6): 217-21.
Francis J, Hunter B, Addy M. A comparision of three delivery methods of chlorhexidine in handicapped children. Effects on plaque, gingivitis and tooth staining. J Periodontol. 1987; 58 (7): 451-5.
Francis J, Addy M, Hunter B. A comparision of three delivery methods of clorhexidine in handicapped children. II. Parent and house-parent preferences. J Periodontol. 1987; 58 (7): 456-9.
Pannuti CM, Saraiva MC, Ferraro A, Falsi D, Cai S, Lotufo RFM. Efficacy of a 0.5% chlorhexidine gel on the control of gingivitis in Brazilian mentally handicapped patients. J Clin Periodontol. 2003; 30 (6): 573-6.
Yoshihara T, Morinushi T, Kinjyo S, Yamasaki Y. Effect of periodic preventive care on the progression of periodontal disease in young adults with Down’s syndrome. J Clin Periodontol. 2005; 32 (6): 556-60.